A/Prof. Prudence Francis
Honorary
The Sir Peter Maccallum Department of Oncology
132 Scholarly works
4 Projects
HIGHLIGHTS
2021
Journal article
Light Enhanced Cognitive Behavioral Therapy (CBT-I Light) for Insomnia and Fatigue During Chemotherapy for Breast Cancer: A Randomized Controlled Trial.
DOI: 10.1093/sleep/zsab2462021
Journal article
Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021.
DOI: 10.1016/j.annonc.2021.06.0232021
Journal article
Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials
DOI: 10.1016/S1470-2045(21)00288-62021
Journal article
Assessment of Ovarian Function in Phase 3 (Neo)adjuvant Breast Cancer Clinical Trials: A Systematic Evaluation.
DOI: 10.1093/jnci/djab1112021
Research Grant
Understanding response to neoadjuvant therapy in hormone receptor positive breast cancer: a correlative analysis of the ELIMINATE Trial
2018
Research Grant
CAPTURE: CIRCULATING TUMOUR DNA ASSESSMENT OF PIK3CA TO GUIDE TREATMENT RESPONSE
2015
Research Grant
THE LANDSCAPE OF CANCER GENES AND ASSOCIATIONS WITH PROGNOSIS IN BREAST CANCER DIAGNOSED IN PREMENOPAUSAL WOMEN
RECENT SCHOLARLY WORKS
2021
Journal article
Heparanase: a potential marker of worse prognosis in estrogen receptor-positive breast cancer
DOI: 10.1038/s41523-021-00277-x2021
Conference Proceedings
Feasibility of implementing a pharmacist-led DPYD gene testing service for patients commencing 5-fluorouracil (5FU) or capecitabine.
DOI: 10.1200/jco.2021.39.15_suppl.e186442021
Journal article
Challenges in Adjuvant Therapy for Premenopausal Women Diagnosed With Luminal Breast Cancers.
DOI: 10.1200/EDBK_3205952021
Conference Proceedings
The role of CYP2D6 mediated tamoxifen metabolism in the suppression of ovarian function trial (SOFT)
DOI: 10.1158/1538-7445.sabcs20-pd2-092020
Journal article
5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)
DOI: 10.1016/j.annonc.2020.09.0102020
Journal article
Response to letter commenting on: Fulvestrant falsely elevates oestradiol levels in immunoassays in postmenopausal women with breast cancer
DOI: 10.1016/j.ejca.2020.06.006
RECENT PROJECTS
2016
Research Grant
RANDOMISED PHASE III TRIAL OF ADJUVANT RADIOTHERAPY VERSUS OBSERVATION FOLLOWING BREAST CONSERVING SURGERY AND ENDOCRINE THERAPY IN PATIENTS WITH MOLECULARLY CHARACTERISED LOW-RISK LUMINAL A EARLY BREAST CANCER